·
8 Min Read

Malaria cases, RSV vaccine, new maternal mortality & e-cigarette studies with Andrea Garcia, JD, MPH

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the RSV vaccine, Malaria cases and more.

series
Prevention & Wellness
AMA Update
·
8 Min Read

Malaria cases, RSV vaccine, new maternal mortality & e-cigarette studies with Andrea Garcia, JD, MPH [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the RSV vaccine, Malaria cases and more.

series
Prevention & Wellness
AMA Update Podcast
·
14 Min Read

June 30, 2023: National Advocacy Update

Congressional hearing held to examine Medicare physician payment system and more in the latest National Advocacy Update.

Advocacy Update
·
5 Min Read

June 30, 2023: State Advocacy Update

How South Dakota’s licensure applications support physician wellness and more in the latest State Advocacy Update.

Advocacy Update
Doctor using stethoscope on a pregnant patient
·
5 Min Read

Boosting treatment for incarcerated pregnant patients with SUDs

Pregnant people with a substance use disorder have the same right to treatment as any other person with an SUD. Learn more.

Behavioral Health
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of June 19, 2023

In the news: New CDC director named, USPPSTF recommends screen adults for anxiety, invasive bacteria in Gulf States, e-cigarette sales and more.

Publications & Newsletters
·
9 Min Read

June 16, 2023: National Advocacy Update

Highlights from the 2023 AMA Annual Meeting and more in the latest National Advocacy Update.

Advocacy Update
Meeting of the 2023 AMA House of Delegates
·
35 Min Read

Highlights from the 2023 AMA Annual Meeting

Track the news and key moments from the AMA House of Delegates’ meeting, which ran June 9–13.

Annual Meeting
2023 Annual Meeting delegates from Kansas and Missouri
·
4 Min Read

Put naloxone in schools so it can save lives

Opioid overdose-reversing drugs such as naloxone save lives. They should be available in educational settings and public areas, the AMA says.

Behavioral Health